Learn / BCAX
NASDAQ: BCAX
Bicara Therapeutics (BCAX) stock, explained like you're 5
Bicara Therapeutics trades on the Nasdaq under the ticker BCAX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.
- Ticker
- BCAX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.2 billion dollars
Is Bicara Therapeutics a small, medium or large cap company?
No. Bicara Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Bicara Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BCAX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value (Yahoo Finance)
- (BCAX) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
- Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
- Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary (Yahoo Finance)
- BCAX Forecast Price Target Prediction for 2027 (TradingView)
Follow BCAX in your daily brief
Each trading day at 5 PM ET we post what happened to Bicara Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BCAX
Questions about Bicara Therapeutics stock
What does Bicara Therapeutics do?
Bicara Therapeutics trades on the Nasdaq under the ticker BCAX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.
What is the ticker symbol for Bicara Therapeutics?
Bicara Therapeutics trades under the ticker BCAX on the Nasdaq.
What is Bicara Therapeutics's market cap?
Bicara Therapeutics is a small cap stock with a market cap of about 1.2 billion dollars.
How does Bicara Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BCAX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BCAX stock every day?
Add BCAX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.